Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Cancer Chemotherapy and Pharmacology|January 1, 1991
Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancerP Jakobsen, E Steiness, L Bastholt, et al.
Cardiology|January 1, 1992
Rapid estimation of left ventricular ejection fraction in acute myocardial infarction by echocardiographic wall motion analysisJ Berning, J Rokkedal Nielsen, J Launbjerg, et al.
Clinical Genetics|September 5, 2013
National mutation study among Danish patients with hereditary haemorrhagic telangiectasiaP M Tørring, K Brusgaard, L B Ousager, et al.
Seminars in Cutaneous Medicine and Surgery|September 29, 2009
Optical coherence tomography for imaging of skin and skin diseasesMette Mogensen, L Thrane, T M Joergensen, et al.
American Journal of Surgery|December 1, 1996
Selective neck dissection and the management of the node-positive neckS J Traynor, J I Cohen, J Gray, et al.
The Annals of Otology, Rhinology, and Laryngology|July 24, 2001
Tracheoesophageal puncture in the office setting with local anesthesiaS Desyatnikova, J J Caro, P E Andersen, et al.
American Journal of Surgery|November 1, 1995
Differentiated carcinoma of the thyroid with extrathyroidal extensionP E Andersen, J Kinsella, T R Loree, et al.
Breast Cancer Research and Treatment|August 15, 2000
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of ageC Rose, C Kamby, H T Mouridsen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurementP Jakobsen, L Bastholt, M Dalmark, et al.
Breast Cancer Research and Treatment|January 1, 1986
Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisoneC Rose, C Kamby, H T Mouridsen, et al.
Pageof 17